A 12-Week Prospective, Double-Blind, Multicenter, Randomized Study Comparing 100 Units of Abobotulinum Toxin Type A (Dysport<sup>®</sup>) and 33.33 Units of Neubotulinum Toxin Type A (Neuronox<sup>®</sup>) for the Treatment of Hemifacial Spasm

A 12-Week Prospective, Double-Blind, Multicenter, Randomized Study Comparing 100 Units of Abobotulinum Toxin Type A (Dysport<sup>®</sup>) and 33.33 Units of Neubotulinum Toxin Type A (Neuronox<sup>®</sup>) for the Treatment of Hemifacial Spasm

Previous randomized controlled trials (RCTs) investigating Botulinum toxin A (BoNT-A) for treatment of hemifacial spasm (HFS) have primarily focused on symptom relief and quality-of-life improvement. However, head-to-head comparisons of different BoNT-A formulations, particularly in terms of onset,...

Full description

Saved in:
Bibliographic Details
Main Authors: Subsai Kongsaengdao, Arkhom Arayawichanont, Kanoksri Samintharapanya, Pichai Rojanapitayakorn, Benchalak Maneeton, Narong Maneeton
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Toxins
Subjects:
hemifacial spasm
botulinum Toxin A
quality of life
sleep quality
depression
Online Access:https://www.mdpi.com/2072-6651/17/4/173
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2072-6651/17/4/173

Similar Items